We are live on
!
Find out more
JCM
JS Capital Management Portfolio holdings
AUM
$109M
1-Year Est. Return
34.13%
This Fund
S&P 500
This Quarter
Est. Return
-25.7%
1 Year Est. Return
-34.13%
3 Year Est. Return
-16.34%
5 Year Est. Return
-37.7%
10 Year Est. Return
+464.39%
AUM
$1.29B
AUM Growth
-$913M
(-41%)
Cap. Flow
-$276M
Cap. Flow
% of AUM
-21.44%
Top 10 Holdings %
Top 10 Hldgs %
83.04%
Holding
43
New
6
Increased
10
Reduced
8
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Avis
CAR
|
+$27.4M |
| 2 |
Cardlytics
CDLX
|
+$23.4M |
| 3 |
Booking.com
BKNG
|
+$23.4M |
| 4 |
Microsoft
MSFT
|
+$18.1M |
| 5 |
Expedia Group
EXPE
|
+$16.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snowflake
SNOW
|
+$136M |
| 2 |
10x Genomics
TXG
|
+$80.5M |
| 3 |
DIDI
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
|
+$30.6M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$30.5M |
| 5 |
Clarivate
CLVT
|
+$21.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 68.96% |
| 2 | Technology | 10.61% |
| 3 | Communication Services | 9.01% |
| 4 | Industrials | 8.37% |
| 5 | Financials | 2.58% |
Similar funds
SC
WP
CFM
EWM
PL
PC
DHC
KWM
JS Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, JS Capital Management held 43 positions worth $1.29B, down 41% from $2.2B the previous quarter. Its ten largest holdings account for 83% of the portfolio.
JS Capital Management withdrew a net $276M in Q1 2022, closing 15 positions and reducing 8 holdings. Its most notable exit was 10x Genomics, an estimated $80.5M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 69% of assets, up from 63% a quarter earlier, followed by Technology and Communication Services.
Against the trend, JS Capital Management opened a new position in Avis worth $35.8M.
- JS Capital Management's largest Q1 2022 buy was Avis: 136,000 shares worth $35.8M.
- JS Capital Management added most to Cardlytics in Q1 2022, an estimated $23.4M increase.
- JS Capital Management's biggest Q1 2022 reduction was Snowflake, cutting an estimated $136M.
- JS Capital Management fully exited 10x Genomics in Q1 2022, selling an estimated $80.5M.
- JS Capital Management's ten largest holdings make up 83% of its $1.29B portfolio in Q1 2022.
- JS Capital Management opened 6 new positions and closed 15 in Q1 2022.
- JS Capital Management's portfolio value fell 41% quarter-over-quarter to $1.29B.
Based on JS Capital Management's 13F filing for Q1 2022, filed 16 May 2022.